Adm Tronics Unlimited Inc (ADMT) 0.1631 $ADMT A
Post# of 273333
Posted On: 09/22/2016 7:09:05 PM
Adm Tronics Unlimited Inc (ADMT) 0.1631 $ADMT
ADM Tronics CEO Comments on First Quarter Fiscal Year 2017 Financial Results
PR Newswire - Tue Aug 23, 7:30AM CDT
Andre' DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, commented on ADMT's first quarter of fiscal year 2017 financial results reported yesterday in the Company's quarterly report on Form 10Q available at www.sec.gov.
ADM Tronics Reports First Quarter of Fiscal Year 2017 Results, Revenues Increase 31%
PR Newswire - Mon Aug 22, 3:01PM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its first fiscal quarter ended June 30, 2016 of Fiscal Year 2017.
ADM Tronics Reports Second Quarter of Fiscal Year 2016 Results, Revenues Increase 67%
PR Newswire - Mon Nov 23, 9:54AM CST
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its second quarter ended September 30, 2015 of Fiscal Year 2016.
ADM Tronics Announces FDA 510(k) Application Filed for Angiodroid CO2 Injector for Angiography
PR Newswire - Wed Oct 14, 8:14AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that a Premarket Notification 510(k) application has been filed with the US Food and Drug Administration ("FDA"
for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector" by Angiodroid America, Inc., a subsidiary of Angiodroid, Srl, in affiliation with Triotech Ventures and ADMT, as previously announced.
ADM Tronics Reports First Quarter of Fiscal Year 2016 Results, Revenues Increase 69%
PR Newswire - Fri Aug 14, 12:26PM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its first quarter ended June 30, 2016 of Fiscal Year 2016.
ADM Tronics Receives Strategic Investment from Advanced Plasma Therapies
PR Newswire - Mon Aug 10, 8:00AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced today that Advanced Plasma Therapies Inc. ("APT", a privately-held company involved in the development and commercialization of innovative therapeutic medical plasma technologies, has invested $300,000 in ADMT in exchange for 2,068,965 shares of ADMT common stock. The shares purchased by APT are restricted securities and have not been registered for public sale.
ADM Tronics Reports Fiscal Year 2015
PR Newswire - Tue Jul 14, 8:00AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its fiscal year ended March 31, 2015.
ADM Tronics Launches Second Expansion of Medical Device Design and Engineering Capabilities
PR Newswire - Tue Apr 21, 9:30AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) is again expanding due to increased demand from customers for medical device design and development project activities and orders. As announced in September of 2014, the Company's initial expansion followed the near doubling of ADMT's revenues for the first quarter, ended June 30, 2014 of the fiscal year ended March 31, 2015, as compared to the same quarter of the previous year. That expansion included the addition of engineering staff and the acquisition of additional rapid 3D prototyping and other equipment.
Dr. S. Vincent Grasso Joins ADM Tronics as Chief Medical Information Officer
PR Newswire - Tue Oct 21, 8:15AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that S. Vincent Grasso, DO, MSIS, MBA has joined the company as Chief Medical Information Officer (CMIO).
ADM Tronics CEO Comments on First Quarter Fiscal Year 2017 Financial Results
PR Newswire - Tue Aug 23, 7:30AM CDT
Andre' DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, commented on ADMT's first quarter of fiscal year 2017 financial results reported yesterday in the Company's quarterly report on Form 10Q available at www.sec.gov.
ADM Tronics Reports First Quarter of Fiscal Year 2017 Results, Revenues Increase 31%
PR Newswire - Mon Aug 22, 3:01PM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its first fiscal quarter ended June 30, 2016 of Fiscal Year 2017.
ADM Tronics Reports Second Quarter of Fiscal Year 2016 Results, Revenues Increase 67%
PR Newswire - Mon Nov 23, 9:54AM CST
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its second quarter ended September 30, 2015 of Fiscal Year 2016.
ADM Tronics Announces FDA 510(k) Application Filed for Angiodroid CO2 Injector for Angiography
PR Newswire - Wed Oct 14, 8:14AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that a Premarket Notification 510(k) application has been filed with the US Food and Drug Administration ("FDA"
for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector" by Angiodroid America, Inc., a subsidiary of Angiodroid, Srl, in affiliation with Triotech Ventures and ADMT, as previously announced. ADM Tronics Reports First Quarter of Fiscal Year 2016 Results, Revenues Increase 69%
PR Newswire - Fri Aug 14, 12:26PM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its first quarter ended June 30, 2016 of Fiscal Year 2016.
ADM Tronics Receives Strategic Investment from Advanced Plasma Therapies
PR Newswire - Mon Aug 10, 8:00AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced today that Advanced Plasma Therapies Inc. ("APT"
, a privately-held company involved in the development and commercialization of innovative therapeutic medical plasma technologies, has invested $300,000 in ADMT in exchange for 2,068,965 shares of ADMT common stock. The shares purchased by APT are restricted securities and have not been registered for public sale. ADM Tronics Reports Fiscal Year 2015
PR Newswire - Tue Jul 14, 8:00AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its fiscal year ended March 31, 2015.
ADM Tronics Launches Second Expansion of Medical Device Design and Engineering Capabilities
PR Newswire - Tue Apr 21, 9:30AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) is again expanding due to increased demand from customers for medical device design and development project activities and orders. As announced in September of 2014, the Company's initial expansion followed the near doubling of ADMT's revenues for the first quarter, ended June 30, 2014 of the fiscal year ended March 31, 2015, as compared to the same quarter of the previous year. That expansion included the addition of engineering staff and the acquisition of additional rapid 3D prototyping and other equipment.
Dr. S. Vincent Grasso Joins ADM Tronics as Chief Medical Information Officer
PR Newswire - Tue Oct 21, 8:15AM CDT
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that S. Vincent Grasso, DO, MSIS, MBA has joined the company as Chief Medical Information Officer (CMIO).
(0)
(0)